- Adamson AS, Jarmul JA, Pignone MP. Screening for Melanoma in Men: a Cost-Effectiveness Analysis. J Gen Intern Med. 2019.
- Barichello S, Deng L, Ismond KP, Loomes DE, Kirwin EM, Wang H, et al. Comparative effectiveness and cost-effectiveness analysis of a urine metabolomics test vs. alternative colorectal cancer screening strategies. Int J Colorectal Dis. 2019;34(11):1953-62.
- Booth N, Rissanen P, Tammela TLJ, Kujala P, Stenman UH, Taari K, et al. Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data. PLoS One. 2019;14(11):e0224479.
- Criss SD, Cao P, Bastani M, Ten Haaf K, Chen Y, Sheehan DF, et al. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study. Ann Intern Med. 2019.
- Muhlenbruch K, Zhuo X, Bardenheier B, Shao H, Laxy M, Icks A, et al. Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis. Acta Diabetol. 2019.
- O'Mahony JF, Paulden M. The Joint Committee on Vaccination and Immunisation's Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision? Value Health. 2019;22(11):1227-30.
- Otero HJ, Degnan AJ, Kadom N, Neumann PJ, Lavelle TA. Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus Far. J Am Coll Radiol. 2019.
HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Monday 16 December 2019
November’s CEAs.....
We’ve completed our quick search for CEA’s published last month. In the right-hand column of this blog is a CEA Archive of all records. Below are those in our areas of interest.